Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 2-Reference-Cited by-同舟云学术

Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 2

Published:1999-07-01 Issue:15 Volume:42 Page:2760-2773
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Quan Mimi L.¹,Ellis Christopher D.¹,Liauw Ann Y.¹,Alexander Richard S.¹,Knabb Robert M.¹,Lam Gilbert¹,Wright Matthew R.¹,Wong Pancras C.¹,Wexler Ruth R.¹

Affiliation:

1. DuPont Pharmaceuticals Company, Experimental Station, P.O. Box 80500, Wilmington, Delaware 19880-0500

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm980406a

Reference24 articles.

1. Optimization of conditions for the catalytic effect of the factor IXa - Factor VIII complex

2. Ripka, W. C.; Vlasuk, G. P. Antithrombotics/Serine Proteases. InAnnualReports in Medicinal Chemistry; Bristol, J. A., Ed.; Academic Press: New York, 1997, Vol. 32, pp 71−89.

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New phenylisoxazole derivatives: Synthesis, spectroscopic, X-ray, IR, DFT calculation and biological activity studies;Journal of Molecular Structure;2023-08

2. Novel Isosteviol-Based FXa Inhibitors: Molecular Modeling, In Silico Design and Docking Simulation;Molecules;2023-06-24

3. Discovery and development of Factor Xa inhibitors (2015–2022);Frontiers in Pharmacology;2023-02-21

4. Asymmetric Fluorofunctionalizations with Carboxylate‐Based Phase‐Transfer Catalysts;The Chemical Record;2023-02-03

5. Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE);Journal of Medicinal Chemistry;2021-08-26